Hedge Fund News: Warren Buffett, Bill Ackman & John Paulson
Timing isn't everything, but it sure helps. Six years ago, Warren Buffett, chairman of Berkshire Hathaway Inc.
Elan Plc (ELN)
This company is not actively trading or the ticker does belong to another company in our database now.
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 40 North Management David S. Winter And David J. Millstone | 0 | $0 | 0% | |
| 3. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
| 4. | Jet Capital Investors Matthew Mark | 0 | $0 | 0% | |
| 5. | Twin Capital Management David Simon | 0 | $0 | 0% |
Institutional Investors' Holdings
News See All
John Paulson's Favorite Themes Are Discount Retail, Domestic Energy and FedEx
While John Paulson’s name is synonymous with outsized bets on mortgage-backed securities and gold, he also runs a fairly large equity portfolio at Paulson & Co, and it’s worth tracking.
Ken Griffin Prefers Biotech to Large-Caps Like Apple & Priceline
Biotech bets. The first thing to know about Citadel and Ken Griffin is that they typically employ a high level of portfolio turnover on a quarterly basis.
Clint Carlson's New Favorites Include Bunge & WellPoint
Clint Carlson of Carlson Capital has also shared his big bets from this fall.
Hedge Fund News: Ken Griffin's Retail Moves, Marc Faber & Darren Read
A growing number of managers of very large, well-known hedge fund firms have been going on a shopping spree, placing big bets on name-brand retailers or their suppliers in recent weeks.
Is This the End of Steven Cohen's Insider Trading Battle?
Steven Cohen insider trading: It's no secret that Steven Cohen and SAC Capital are going through a rough patch, mainly because of the insider trading lawsuit initiated by the Securities and Exchange ...
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it's the year of biotech.
GlaxoSmithKline plc (ADR) (GSK), Pfizer Inc. (PFE): Theravance Inc (THRX) Gets Big Win for New COPD Drug
Trading of biopharmaceutical company Theravance Inc (NASDAQ:THRX) was halted on Tuesday. A major decision hung in the balance as the U.S.
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Investors Should Brace for a Busy Week From the Biotech Sector
With second-quarter earnings season now in the books and about a month to go before third-quarter earnings kicks off, biotech savvy investors are in for a treat this week with three separate events from...
J.C. Penney Company, Inc. (JCP), Perrigo Company (PRGO), Cabot Oil & Gas Corporation (COG): Shorts Are Piling Into These Stocks. Should You Be Worried?
The best thing about the stock market is that you can make money in either direction. Historically, stock indexes have tended to trend up over the long term.
Hedge Fund Resource Center